Metadata
Author: EurLex-2
Data
Bulgarian[bg]
(Дело M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)
Czech[cs]
(Věc M.7872 – Novartis/GSK (Ofatumumab Autoimmune Indications))
Danish[da]
(Sag M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications))
German[de]
(Sache M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications))
Greek[el]
[Υπόθεση M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)]
English[en]
(Case M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications))
Spanish[es]
[Asunto M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)]
Estonian[et]
(juhtum M.7872 – Novartis / GSK (Ofatumumab Autoimmune Indications))
Finnish[fi]
(Asia M.7872 – Novartis / GSK (Ofatumumab Autoimmune Indications))
French[fr]
[Affaire M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)]
Croatian[hr]
(Predmet M.7872 – Novartis/GSK (Ofatumumab Autoimmune Indications))
Hungarian[hu]
(Ügyszám: M.7872 – Novartis/GSK (Ofatumumab Autoimmune Indications))
Italian[it]
[Caso M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)]
Lithuanian[lt]
(Byla M.7872 – Novartis / GSK (Ofatumumabo Autoimuninės Indikacijos))
Latvian[lv]
(Lieta M.7872 – Novartis/GSK (Ofatumumab Autoimmune Indications))
Maltese[mt]
(Il-Każ M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications))
Dutch[nl]
(Zaak M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications))
Polish[pl]
(Sprawa M.7872 – Novartis/GSK (Ofatumumab Autoimmune Indications))
Portuguese[pt]
[Processo M.7872 — Novartis/GSK (Ofatumumab Autoimmune Indications)]
Romanian[ro]
[Cazul M.7872 – Novartis/GSK (Ofatumumab Autoimmune Indications)]
Slovak[sk]
[Vec M.7872 – Novartis/GSK (Ofatumumab Autoimmune Indications)]
Slovenian[sl]
(Zadeva M.7872 – Novartis/GSK (Ofatumumab Autoimmune Indications))
Swedish[sv]
(Ärende M.7872 – Novartis/GSK [Ofatumumab Autoimmune Indications])